USA: PNS to Start Energy Efficient Upgrades

first_img View post tag: PNS January 7, 2013 View post tag: Naval View post tag: start View post tag: to Naval Facilities Engineering Command (NAVFAC) Mid-Atlantic awarded a contract Dec. 28 for energy improvements and repairs to the historic Building 92 structural shops at Portsmouth Naval Shipyard in Kittery, Maine.The $13.8 million project is projected to reduce the building’s annual energy consumption by 82 percent through the use of renewable energy, efficient heating, ventilation, and air conditioning and electrical systems, and smart metering technology.“In an industrial facility such as Building 92 structural shops, and in a climate such as Maine, the primary energy driver is building heat,” said Lee Enzastiga, NAVFAC Mid-Atlantic project manager for the Northeast Integrated Products Team. “An energy recovery system will be installed to recover heat being exhausted from the industrial process exhaust and transfer that heat to the incoming air to the building.”A new, large polycarbonate window system will replace a deteriorating window wall and also help reduce energy costs while still preserving the historic character of the building’s exterior walls which cover nearly 30,000 square feet of this submarine fabrication and repair facility.“The new window system will be a translucent curtain wall system that resembles the historic configuration of the existing window system but increases the R-value and prevents air infiltration,” Enzastiga said. The higher the R-value, or the thermal resistance of a material, the better the material is at insulating, he added.Large exterior overhead doors will be replaced or refurbished and large fans will be installed in middle and high bays to draw down the large amount of heat trapped at the high ceiling so it can be used to heat other areas in the building.The project also incorporates several renewable energy technologies such as a solar wall that will preheat air by solar radiation, fans that will feed the preheated air into the building, and hot water coils that will supplement the solar heat. The building’s automated heating system will manage the operation of the fans so they only run when it is efficient to do so.Lastly, a new lighting management system will adjust interior lighting accordingly to maximize natural daylight use from the new window wall.The competitively procured contract was awarded to ECC of Marlborough, Mass. Work will be performed in Kittery, Maine and is expected to be completed by October 2014.[mappress]Naval Today Staff, January 7, 2013; Image: US Navy View post tag: Navy Back to overview,Home naval-today USA: PNS to Start Energy Efficient Upgrades View post tag: energy Industry news View post tag: Defence View post tag: efficient View post tag: News by topic View post tag: Upgrades View post tag: Defense USA: PNS to Start Energy Efficient Upgrades Share this articlelast_img read more

Read More →

FDA clears single test for 12 respiratory viruses

first_imgEditor’s note: This story was revised Jan 8 to correct information about the location of the test’s manufacturer. Jan 7, 2008 (CIDRAP News) – A single test that can identify up to 12 different respiratory viruses, including three kinds of influenza, from one sample has won the Food and Drug Administration’s (FDA’s) approval.The test, called the xTAG Respiratory Viral Panel (RVP), is the first that can detect and distinguish influenza A subtypes H1 and H3 and also detect influenza B, the FDA said in announcing the approval on Jan 3. Influenza A is the most severe type of flu in humans and has been the cause of pandemics, the agency noted.The new test panel is also the first test for human metapneumovirus (hMPV), which was first identified in 2001, the FDA said.The test is made by Toronto-based Luminex Molecular Diagnostics, part of Luminex Corp, headquartered in Austin, Tex. In a news release, the company called the xTAG RVP “a ground breaking test that, with a single patient sample, can assess the presence or absence of 12 viral targets and provide qualitative results in a few hours.”Conventional testing for the same viruses requires a number of separate tests and can take several days, the company said. The new product will help physicians provide appropriate treatment and prevent inappropriate antibiotic use that has helped spawn resistant microbes, the statement said.The FDA said, “The xTAG panel is the first FDA-cleared test for infectious respiratory disease viruses that uses a multiplex platform, allowing several tests to be processed using the same sample.”The test uses polymerase chain reaction (PCR) to amplify viral genetic material in samples from patients, according to Jeremy Bridge-Cook, vice president of Luminex Molecular Diagnostics. The FDA said the test uses secretions from the back of the throat.The test uses tiny color-coded beads, or microspheres, that are coated with reagents specific to material from particular viruses, according to information on the Luminex Web site.”There’s a different color-coded bead for each virus in the test,” Bridge-Cook told CIDRAP News. “The Luminex instrument can identify the different color-coded beads and whether the viral target was amplified. If any of the beads is positive, that indicates whether the viral target was present in the sample.”The use of PCR to reproduce viral material “speeds up the usual process of detecting and identifying respiratory viruses, which can take up to a week,” Daniel D. Schultz, MD, director of the FDA’s Center for Devices and Radiological Health, said in the news release.The FDA said viruses identified by the xTAG RVP, in addition to the three forms of influenza and human metapneumovirus, include:Respiratory syncytial virus subtypes A and B, both of which are leading causes of infant pneumonia and bronchiolitis and often contribute to the development of long-term lung diseaseParainfluenza 1, 2, and 3—all leading factors in croup and the common coldRhinovirus, the most common viral infective agent in humans and another cause of the common coldAdenovirus, a cause of respiratory tract infections often similar to strep throat or tonsillitisThe 12 viruses covered by the test account for more than 85% of respiratory viral infections, the Luminex statement said.The company said the test’s ability to identify influenza subtypes H1 and H3 will be important in efforts to detect quickly any emerging pandemic flu virus. The test will make it possible to sort H1 and H3 viruses, which make up the vast majority of influenza A subtypes, from rare forms of influenza A. “This way, the few samples that do test positive for influenza A but cannot be identified as H1 or H3 subtypes can be flagged for further investigation by the CDC or local public health labs,” the company said.Bridge-Cook said the time needed to run the test will vary, but “I’d say maybe 6 hours might be a typical time.”As for the cost, he said he couldn’t give a specific figure, but added, “From a ballpark standpoint, basically the number is in the low hundreds [of dollars], as opposed to thousands of dollars, with respect to what it costs the healthcare system as a whole when the test is run.”Bridge-Cook said the test requires specially trained personnel, so it’s likely to be used mainly in hospital laboratories. But he said many hospital labs take samples from outpatient clinics, so the test would not be limited to use on inpatients.The FDA said that because the test is specific to the 12 viruses listed, it should be used with other diagnostic information, such as patient data, bacterial or viral cultures, and x-rays.See also: Jan 3 FDA news releasehttp://www.fda.gov/bbs/topics/NEWS/2008/NEW01770.htmlJan 3 Luminex news releasehttp://phx.corporate-ir.net/phoenix.zhtml?c=79403&p=irol-newsArticle&ID=1091216&highlight=last_img read more

Read More →

Arsenal Targets Win to Banish Runners-up Tradition

first_imgUEFA CHAMPIONS LEAGUEArsenal have a gilt-edged opportunity to kick a self-destructive Champions League habit when they host Paris St Germain this evening knowing victory will seal top spot in group A.The north Londoners have fallen in the last-16 in each of the past six seasons and during that period only once did they finish first in their initial group.Their punishment for finishing runners-up on the other five occasions was harsh, twice being drawn against Bayern Munich and twice against Barcelona, losing all four ties, while even when fortune did favour them they succumbed to Monaco. Even if they do beat PSG, who are level on 10 points with the Gunners, on Wednesday the spectre of a horror draw against Bayern or Barcelona would still exist.Neither of those two clubs are guaranteed top spot in their respective sections and could lurk as runners-up but unless Arsene Wenger owns a crystal ball he can only assume that finishing top will be rewarded.Ultimately, luck of the draw will play its part but an Arsenal victory would maintain the positive vibe of their campaign to date and fire out a message to their rivals.Olivier Giroud’s late equaliser against Manchester United on Saturday means Arsenal are unbeaten in 17 matches in all competition since losing to Liverpool on the opening day of the season while PSG are on a nine-game undefeated run.Arsenal have drawn three of their last four Premier League games and should tonight’s match end all square, the battle for top spot will go down to the final round of games when Arsenal travel to Basel and PSG host Ludogorets.While Arsenal’s level has dipped in recent weeks, Wenger believes his side’s resilience will be key against PSG.“Hopefully we can move on with some wins, we have a big game on Wednesday against Paris Saint-Germain and that will be the same intensity,” he said after the United draw.“I am convinced that we will be better on Wednesday.”PSG warmed up with a 2-0 defeat of Nantes at the weekend although suffered an injury scare when Angel Di Maria was withdrawn in the first half because of a hamstring niggle.Coach Unai Emery later said he was confident the Argentine winger will be fit to face Arsenal.Share this:FacebookRedditTwitterPrintPinterestEmailWhatsAppSkypeLinkedInTumblrPocketTelegramlast_img read more

Read More →